These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 1826013

  • 1. Regulation by glutathione of the effect of lymphokines on differentiation of primary activated lymphocytes. Influence of glutathione on cytotoxic activity of CD3-AK-.
    Liang SM, Liang CM, Hargrove ME, Ting CC.
    J Immunol; 1991 Mar 15; 146(6):1909-13. PubMed ID: 1826013
    [Abstract] [Full Text] [Related]

  • 2. Regulation by glutathione of the activation and differentiation of IL-4-dependent activated killer cells.
    Hargrove ME, Wang J, Ting CC.
    Cell Immunol; 1993 Jul 15; 149(2):433-43. PubMed ID: 8330319
    [Abstract] [Full Text] [Related]

  • 3. Glutathione modulates activation-dependent proliferation of human peripheral blood lymphocyte populations without regulating their activated function.
    Smyth MJ.
    J Immunol; 1991 Mar 15; 146(6):1921-7. PubMed ID: 2005386
    [Abstract] [Full Text] [Related]

  • 4. In vivo antitumor activity of anti-CD3-induced activated killer cells.
    Yun YS, Hargrove ME, Ting CC.
    Cancer Res; 1989 Sep 01; 49(17):4770-4. PubMed ID: 2527087
    [Abstract] [Full Text] [Related]

  • 5. Anti-CD3 + IL-2-stimulated murine killer cells. In vitro generation and in vivo antitumor activity.
    Anderson PM, Blazar BR, Bach FH, Ochoa AC.
    J Immunol; 1989 Feb 15; 142(4):1383-94. PubMed ID: 2521662
    [Abstract] [Full Text] [Related]

  • 6. IL-4 regulation of perforin gene expression and BLT-esterase production in alpha CD3-induced activated killer cells.
    Ting CC, Liang SM, Wang J, Chen YY, Hargrove M, Xu N.
    Biotechnol Ther; 1989 Feb 15; 5(3-4):99-115. PubMed ID: 8608327
    [Abstract] [Full Text] [Related]

  • 7. IL-2 and IL-4 mediate through two distinct kinase pathways for the activation of alphaCD3-induced activated killer cells.
    Wang J, Hargrove ME, Ting CC.
    Cell Immunol; 1996 Dec 15; 174(2):138-46. PubMed ID: 8954613
    [Abstract] [Full Text] [Related]

  • 8. Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2.
    Yoshizawa H, Chang AE, Shu S.
    J Immunol; 1991 Jul 15; 147(2):729-37. PubMed ID: 1830072
    [Abstract] [Full Text] [Related]

  • 9. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL.
    Lancki DW, Kaper BP, Fitch FW.
    J Immunol; 1989 Jan 15; 142(2):416-24. PubMed ID: 2492047
    [Abstract] [Full Text] [Related]

  • 10. Anti-CD3 and phorbol myristate acetate regulation of MHC unrestricted T cell cytotoxicity. Lack of a requirement for CD3/T cell receptor complex expression during tumor cell lysis.
    Thiele DL, Patel SS, Lipsky PE.
    J Immunol; 1988 May 01; 140(9):3253-60. PubMed ID: 2966209
    [Abstract] [Full Text] [Related]

  • 11. Cognate interactions between helper T cells and B cells. III. Contact-dependent, lymphokine-independent induction of B cell cycle entry by activated helper T cells.
    Noelle RJ, McCann J, Marshall L, Bartlett WC.
    J Immunol; 1989 Sep 15; 143(6):1807-14. PubMed ID: 2476483
    [Abstract] [Full Text] [Related]

  • 12. Distinct regulatory effects of IL-4 and TNF-alpha during CD3-dependent and CD3-independent initiation of human T-cell activation.
    Damle NK, Doyle LV.
    Lymphokine Res; 1989 Sep 15; 8(2):85-97. PubMed ID: 2525210
    [Abstract] [Full Text] [Related]

  • 13. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
    Fujimiya Y, Suzuki Y, Katakura R, Miyagi T, Yamaguchi T, Yoshimoto T, Ebina T.
    Clin Cancer Res; 1997 Apr 15; 3(4):633-43. PubMed ID: 9815731
    [Abstract] [Full Text] [Related]

  • 14. Antitumor effects of interleukin 2 liposomes and anti-CD3-stimulated T-cells against murine MCA-38 hepatic metastasis.
    Loeffler CM, Platt JL, Anderson PM, Katsanis E, Ochoa JB, Urba WJ, Longo DL, Leonard AS, Ochoa AC.
    Cancer Res; 1991 Apr 15; 51(8):2127-32. PubMed ID: 1826232
    [Abstract] [Full Text] [Related]

  • 15. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and gamma/delta TCR+ T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody.
    Aramburu J, Balboa MA, Izquierdo M, López-Botet M.
    J Immunol; 1991 Jul 15; 147(2):714-21. PubMed ID: 1830071
    [Abstract] [Full Text] [Related]

  • 16. Dichotomy of glutathione regulation of the activation of resting and preactivated lymphocytes.
    Ting CC, Hargrove ME, Liang SM, Liang CM, Sharrow SO.
    Cell Immunol; 1992 Jun 15; 142(1):40-53. PubMed ID: 1534039
    [Abstract] [Full Text] [Related]

  • 17. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M, Guy R, Waldmann H, Glennie M, Alexander DR.
    Cell Immunol; 1998 May 01; 185(2):101-13. PubMed ID: 9636688
    [Abstract] [Full Text] [Related]

  • 18. Requirement of thiol compounds as reducing agents for IL-2-mediated induction of LAK activity and proliferation of human NK cells.
    Yamauchi A, Bloom ET.
    J Immunol; 1993 Nov 15; 151(10):5535-44. PubMed ID: 8228244
    [Abstract] [Full Text] [Related]

  • 19. IL-10: a novel cytotoxic T cell differentiation factor.
    Chen WF, Zlotnik A.
    J Immunol; 1991 Jul 15; 147(2):528-34. PubMed ID: 1906502
    [Abstract] [Full Text] [Related]

  • 20. Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells.
    Sherris D, Stohl W, Mayer L.
    J Immunol; 1989 Apr 01; 142(7):2343-51. PubMed ID: 2538506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.